| 1978N-0065 | Skin Bleaching Drug Products | |||||||||||||||||||||||
| FDA Comment Number : | EC127 | |||||||||||||||||||||||
| Submitter : | Dr. Sharon Kessler | Date & Time: | 12/07/2006 11:12:17 | |||||||||||||||||||||
| Organization : | Dr. Sharon Kessler | |||||||||||||||||||||||
| Category : | Health Professional | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| My patient population is largely hispanic-many dyschromias, pigmentary problems in the patient group. Very concerned about the potential of hydroquinone being difficult to get as this is a safe, effective treatment for this group. I use it extensively for pretreatment in laser surgery in ethnic patients (an absolute requirement before they CAN be treated.)Have never seen ochronosis in the 17+ years in practice. | ||||||||||||||||||||||||